PARSHALL B LYNNE - Insider Non-Derivative Transactions at IONIS PHARMACEUTICALS INC (IONS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 15, 2025, PARSHALL B LYNNE's relationship to IONIS PHARMACEUTICALS INC (IONS) is Director, and currently has 61,344 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other IONS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

PARSHALL B LYNNE - Insider Non-Derivative Transactions of IONS Common Stock

PARSHALL B LYNNE - Insider Non-Derivative Transactions at IONS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 16, 2025	Sell -- (Common Stock)	5000	71.74	61344
Sep 3, 2025	Sell -- (Common Stock)	9250	51.49	66344
Sep 3, 2025	Sell -- (Common Stock)	10750	50.42	75594
Aug 7, 2025	Sell -- (Common Stock)	400	42.63	86344
Aug 7, 2025	Sell -- (Common Stock)	4600	41.87	86744
Jul 16, 2025	M -- (Common Stock)	4079	0	91344
Jul 16, 2024	M -- (Common Stock)	4677	0	87265
Dec 29, 2023	Sell -- (Common Stock)	42525	50.19	82588
Dec 29, 2023	M -- (Common Stock)	42525	47.34	125113
Dec 28, 2023	Sell -- (Common Stock)	50000	50.23	82588
Dec 28, 2023	M -- (Common Stock)	50000	47.34	132588
Dec 27, 2023	Sell -- (Common Stock)	25113	51.46	82588
Dec 27, 2023	M -- (Common Stock)	25113	47.34	107701
Sep 27, 2023	Sell -- (Common Stock)	10000	45.13	82588
Jul 18, 2023	M -- (Common Stock)	1777	0	87255
Jul 18, 2023	M -- (Common Stock)	5333	0	92588